Scgb2b10, a member of the secretoglobin family, plays a pivotal role in cellular processes associated with secretoglobin function. It functions as a regulator of cell differentiation, responding to various chemical signals that impact its expression and function in secretoglobin-related processes. The multifaceted nature of Scgb2b10 positions it as a key player in ensuring the proper regulation of diverse cellular functions. The activation of Scgb2b10 involves intricate interactions with various chemicals that modulate different cellular pathways. 9-cis-Retinoic Acid, for instance, indirectly activates Scgb2b10 by promoting cell differentiation, influencing its expression in secretoglobin-related processes. Dexamethasone, a glucocorticoid receptor agonist, up-regulates Scgb2b10 by activating the glucocorticoid receptor, affecting its expression in response to glucocorticoid signaling.
Epidermal Growth Factor (EGF) and retinyl palmitate contribute to Scgb2b10 activation by influencing downstream signaling pathways and promoting cell differentiation, respectively. Forskolin and nicotinic acid elevate cAMP levels, indirectly up-regulating Scgb2b10 and potentially impacting its expression in secretoglobin-related processes. Trichostatin A, a histone deacetylase inhibitor, and rosiglitazone, a PPARγ agonist, modulate chromatin structure and PPARγ signaling, respectively, indirectly up-regulating Scgb2b10 and influencing its role in secretoglobin-related processes. SB203580, an inhibitor of the p38 MAPK pathway, and SB431542, an inhibitor of TGF-β type I receptor, impact Scgb2b10 by dampening p38 MAPK and modulating TGF-β signaling, respectively. GW501516, a PPARδ agonist, and sodium butyrate, a histone deacetylase inhibitor, influence Scgb2b10 expression by targeting PPARδ signaling and chromatin structure, respectively. In summary, Scgb2b10 emerges as a central player in the complex orchestration of cellular processes, with its activation intricately linked to the modulation of various cellular pathways. The diverse range of chemicals influencing Scgb2b10 reflects its significance in ensuring the proper regulation of secretoglobin-related functions and highlights its potential as a key target for further investigations in cellular and molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
Regulator of cell differentiation. 9-cis-Retinoic Acid indirectly activates Scgb2b10 by promoting the differentiation of target cells, potentially influencing its expression and function in secretoglobin-related processes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor agonist. Indirectly up-regulates Scgb2b10 by activating the glucocorticoid receptor, potentially influencing its expression and function in response to glucocorticoid signaling pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor. Modulates chromatin structure, indirectly up-regulating Scgb2b10 and affecting its role in secretoglobin-related processes. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Precursor of NAD+. Indirectly influences Scgb2b10 by modulating cellular NAD+ levels, potentially impacting its expression and function in secretoglobin-related processes. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Peroxisome proliferator-activated receptor gamma (PPARγ) agonist. Indirectly influences Scgb2b10 by activating PPARγ, potentially impacting its expression and function in secretoglobin-related processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. Indirectly up-regulates Scgb2b10 by dampening the p38 MAPK signaling pathway, potentially influencing its expression and function in secretoglobin-related processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibitor of TGF-β type I receptor. Indirectly influences Scgb2b10 by modulating TGF-β signaling, potentially impacting its expression and function in secretoglobin-related processes. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
PPARδ agonist. Indirectly activates Scgb2b10 by influencing PPARδ signaling, potentially impacting its expression and function in secretoglobin-related processes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor. Modulates chromatin structure, indirectly up-regulating Scgb2b10 and affecting its role in secretoglobin-related processes. | ||||||